SPHS
Sophiris Bio, Inc.
SPHS
SPHS
Delisted
SPHS was delisted on the 11th of March, 2020.
32 hedge funds and large institutions have $4.35M invested in Sophiris Bio, Inc. in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
95% less call options, than puts
Call options by funds: $7K | Put options by funds: $130K
Holders
32
Holding in Top 10
–
Calls
$7K
Puts
$130K
Top Buyers
| 1 | +$453K | |
| 2 | +$312K | |
| 3 | +$306K | |
| 4 |
BAM
Belpointe Asset Management
Reno,
Nevada
|
+$86K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$55K |
Top Sellers
| 1 | -$631K | |
| 2 | -$34.3K | |
| 3 | -$32K | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$23K |
| 5 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
-$21K |